SCHEMBL28445014

SCHEMBL28445014

COC(=O)c1cccc2[nH]cc(Cc3ccccc3)c12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 3/20 0.52
CREBBP Q92793 1/20 0.50
ALDH1A1 P00352 4/20 0.48
MAPT P10636 3/20 0.48
TDP1 Q9NUW8 2/20 0.48
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 2/20 0.48
CYP2D6 P10635 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
TSHR P16473 1/20 0.48
NFKB1 P19838 1/20 0.48
BLM P54132 1/20 0.48
PMP22 Q01453 1/20 0.48
HIF1A Q16665 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
GPR84 Q9NQS5 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7497428 0.89 NR4A2 (0.52) NR4A2CREBBPALDH1A1MAPTTDP1
SCHEMBL1748749 0.87 NR4A2 (0.53) NR4A2CREBBPMAPTGPR84POLB
SCHEMBL28440788 0.85 MEN1 (0.53) ALDH1A1MAPTTDP1CYP1A2CYP3A4
SCHEMBL16686899 0.85 NR4A2 (0.58) NR4A2CREBBPALDH1A1MAPTTDP1
SCHEMBL763777 0.82 NR4A2 (0.56) NR4A2CREBBPALDH1A1MAPTTDP1
SCHEMBL5008098 0.82 NR4A2 (0.50) NR4A2CREBBPALDH1A1MAPTTDP1
SCHEMBL16687075 0.81 NR4A2 (0.55) NR4A2CREBBPALDH1A1MAPTTDP1
Hydrochloric Acid SCHEMBL6617774 0.81 NR4A2 (0.55) NR4A2CREBBPALDH1A1MAPTTDP1
SCHEMBL5646963 0.80 HTR2A (0.59) NR4A2CREBBPALDH1A1MAPTTDP1
SCHEMBL8726228 0.80 HTR2A (0.60) NR4A2CREBBPALDH1A1MAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111606928-A Azacyclodiketone compound and preparation method thereof 维清生物科技(上海)有限公司 2020-09-01 CN disclosed